Dr Joseph Meserve, MD | |
3 Richland Medical Park Dr Ste 120, Columbia, SC 29203-6850 | |
(803) 434-8866 | |
(803) 933-3049 |
Full Name | Dr Joseph Meserve |
---|---|
Gender | Male |
Speciality | Internal Medicine - Gastroenterology |
Location | 3 Richland Medical Park Dr Ste 120, Columbia, South Carolina |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1083001473 | NPI | - | NPPES |
Entity Name | Regents Of The University Of California |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1376646869 PECOS PAC ID: 3577476761 Enrollment ID: O20031112000695 |
News Archive
In Florida, preventable ER visits for dental care cost that state $88 million, a new report said. In the meantime, California lawmakers sent the governor a bill for his approval that would give low-income children a new way to get dental care.
In the largest German survey on heart failure to date, investigators found that the overall awareness of heart failure has not increased over the past decade and is not at a satisfactory level.
Kessler Foundation researchers have authored a new article that further elucidates the mechanisms for cognitive fatigue, a disabling symptom that affects many individuals after traumatic brain injury (TBI).
In the first part of a two-part series in the Center for Strategic & International Studies' (CSIS) "Smart Global Health" blog, Alisha Kramer, an intern with the CSIS Global Health Policy Center, and Matt Fisher, project coordinator of the CSIS Project on Global Water Policy and a research assistant at the Global Health Policy Center, provide a brief history of Haiti's cholera outbreak, noting, "Ultimately, by the end of 2011, the outbreak had resulted in over 500,000 infections and 7,000 deaths."
Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited (TSE:4502), today announced the initiation of a global phase III clinical trial evaluating ADCETRIS (brentuximab vedotin) in combination with chemotherapy for the treatment of newly diagnosed CD30-positive mature T-cell lymphoma (MTCL) patients, including patients with systemic anaplastic large cell lymphoma (sALCL) and other types of peripheral T-cell lymphomas.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Joseph Meserve, MD 300 E Mcbee Ave Fl 4, Greenville, SC 29601-2842 Ph: (803) 864-5228 | Dr Joseph Meserve, MD 3 Richland Medical Park Dr Ste 120, Columbia, SC 29203-6850 Ph: (803) 434-8866 |
News Archive
In Florida, preventable ER visits for dental care cost that state $88 million, a new report said. In the meantime, California lawmakers sent the governor a bill for his approval that would give low-income children a new way to get dental care.
In the largest German survey on heart failure to date, investigators found that the overall awareness of heart failure has not increased over the past decade and is not at a satisfactory level.
Kessler Foundation researchers have authored a new article that further elucidates the mechanisms for cognitive fatigue, a disabling symptom that affects many individuals after traumatic brain injury (TBI).
In the first part of a two-part series in the Center for Strategic & International Studies' (CSIS) "Smart Global Health" blog, Alisha Kramer, an intern with the CSIS Global Health Policy Center, and Matt Fisher, project coordinator of the CSIS Project on Global Water Policy and a research assistant at the Global Health Policy Center, provide a brief history of Haiti's cholera outbreak, noting, "Ultimately, by the end of 2011, the outbreak had resulted in over 500,000 infections and 7,000 deaths."
Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited (TSE:4502), today announced the initiation of a global phase III clinical trial evaluating ADCETRIS (brentuximab vedotin) in combination with chemotherapy for the treatment of newly diagnosed CD30-positive mature T-cell lymphoma (MTCL) patients, including patients with systemic anaplastic large cell lymphoma (sALCL) and other types of peripheral T-cell lymphomas.
› Verified 7 days ago
William Cole Andrew, D.O. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 14 Richland Medical Park Dr Ste 320, Columbia, SC 29203 Phone: 803-434-8721 | |
Seetharamprasad Madala, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1801 Sunset Dr, Columbia, SC 29203 Phone: 803-434-4153 Fax: 803-434-4160 | |
Michael Martin, Gastroenterology Medicare: Medicare Enrolled Practice Location: 2 Medical Park Rd, Columbia, SC 29203 Phone: 803-434-6956 | |
Dr. Terry A Grainger, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 8 Richland Medical Park Dr Ste 100, Columbia, SC 29203 Phone: 803-434-3800 Fax: 803-744-2759 | |
Dr. Adelero Olayinka Adebajo, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1520 Laurel St, Columbia, SC 29201 Phone: 803-799-8407 Fax: 803-252-9070 | |
Jeff Z Brooker Jr., MD, RETIRED Gastroenterology Medicare: Medicare Enrolled Practice Location: 1625 Bernardin Ave, Columbia, SC 29204 Phone: 803-251-8985 | |
Dr. Ronald L Collins, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1711 Saint Julian Pl, Columbia, SC 29204 Phone: 803-779-0911 Fax: 803-256-2480 |